Skip to content
MedsAcross

Medicine

Milrinone 20 mg/100 mL injection

Milrinone · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Milrinone 20 mg/100 mL injection is a generic prescription medicine for intravenous use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Protect from freezing. It is recommended that the Flexible Containers be…

Key facts

Active ingredient (INN)
Milrinone
Brand
Sold under the generic name
Strength
20 mg/100 mL
Dosage form
Injection
Route
Intravenous
Packs
10 pouches of 100 mL, 10 cartons of 100 mL, 10 bags of 100 mL and 5 more
Manufacturers
Caplin SterilesIndiaEugiaIndiaGland PharmaIndiaBaxter HealthcareHikma PharmaceuticalsHospiraSagent PharmaceuticalsSomerset Therapeutics
Origin register
US FDA, United States
Storage
Protect from freezing. It is recommended that the Flexible Containers be stored at room temperature, 25°C (77°F), however, brief exposure up to 40°C (104°F) does not adversely affect the product.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C01CE02 Milrinone
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 May 2002
Identifiers
RxCUI 1791840, 1791842DailyMed set ID a2822b12-0560-49d6-ace5-2377c04425e8, 8fd0f93a-6150-4020-b7ee-4b95b520f6ce, 838da14b-c070-4c09-b088-99e7c64d9964 +5NDC 65145-176, 0338-6010, 68083-410 +5Application ANDA219170, ANDA075834, ANDA213585 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 pouch in 1 case / 1 bag in 1 pouch / 100 mL in 1 bag65145-176-10Caplin SterilesIndia25 June 2026
10 pouch in 1 carton / 1 bag in 1 pouch / 100 mL in 1 bag55150-287-10EugiaIndia3 September 2020
10 carton in 1 carton / 1 bag in 1 carton / 100 mL in 1 bag68083-410-10Gland PharmaIndia16 July 2020
10 bag in 1 carton / 100 mL in 1 bag0338-6010-48Baxter Healthcare28 May 2002
10 container in 1 package / 100 mL in 1 container0143-9719-10Hikma Pharmaceuticals21 January 2010
10 pouch in 1 carton / 1 bag in 1 pouch / 100 mL in 1 bag0409-2045-10Hospira4 April 2022
10 bag in 1 carton / 100 mL in 1 bag25021-313-82Sagent Pharmaceuticals15 January 2021
10 pouch in 1 case / 1 bag in 1 pouch / 100 mL in 1 bag70069-872-10Somerset Therapeutics25 March 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 31 December 1987Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Milrinone

Clinical summary

Milrinone is a phosphodiesterase 3 inhibitor indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. It is available as injection for intravenous use. MedsAcross supplies Milrinone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Milrinone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Milrinone 20 mg/100 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.